Phibro Animal Health Corporation (PAHC)
Gross profit margin
Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|
Gross profit | US$ in thousands | 313,092 | 298,237 | 285,400 | 271,377 | 256,882 |
Revenue | US$ in thousands | 993,816 | 960,113 | 935,602 | 833,350 | 800,354 |
Gross profit margin | 31.50% | 31.06% | 30.50% | 32.56% | 32.10% |
June 30, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $313,092K ÷ $993,816K
= 31.50%
The gross profit margin of Phibro Animal Health Corporation has been relatively stable over the past five years, ranging from 30.50% to 32.56%. The company's ability to generate profits from its core operations has remained consistent, with a slight improvement seen in the most recent fiscal year. Overall, Phibro Animal Health Corporation has maintained a healthy gross profit margin, indicating effective cost management and pricing strategies within its operations.
Peer comparison
Jun 30, 2024
Company name
Symbol
Gross profit margin
Phibro Animal Health Corporation
PAHC
31.50%
Abbott Laboratories
ABT
20.40%
AbbVie Inc
ABBV
16.39%
Alkermes Plc
ALKS
42.73%
Amphastar P
AMPH
51.08%
ANI Pharmaceuticals Inc
ANIP
11.30%
Arcus Biosciences Inc
RCUS
41.86%
Biomarin Pharmaceutical Inc
BMRN
79.61%
Bristol-Myers Squibb Company
BMY
34.23%
Catalent Inc
CTLT
21.75%
Catalyst Pharmaceuticals Inc
CPRX
45.19%